Maybe be another Transmile, Wirecard, Hin Leong, Enron,etc

ionlywanttoearn, this theme can only be used for healthy companies.

No one knows exactly how deep is the audit issue unless you are the company management.

Assuming the audit results from independent review that the orderbook is fake, even at RM0.10, no one is willing to buy.

There's more than 100 companies out there to buy.

Stay safe.

wallstreetrookie, there's a few like Xpeng, NIO, Vinfast.

However, not easy to be part of their supply chain, Greatech must prove themself.

Back then, Hibiscus has this mission statement. I guess it didn't achieve.

Mission (2017 – 2021)
We have disclosed our business objectives for the period 2017 to 2021. These business goals are
repeated herewith:
• 100 mmbbls net proven and probable oil reserves/entitlement in existing core asset areas;
and,
• 20,000 bbls/day net production.

Over the last 4 years, the company had been on a acquiring spree for new assets, many private placements but the share price consistently around rm1 and below.

Yinson management reply?
Normally, they will address it in proper channel like Bursa Malaysia or press conference.

Thanks icst1975


I missed the AGM earlier.

Going for another limit down today at closing?

https://finance.yahoo.com/news/broadcom-avgo-q2-earnings-revenues-133601727.html

What a shame for SD.
A darling among O&G.
But could feel something amiss since IPO where it kept producing impressive results and orderbook growing despite pandemic.

No much catalyst for upside in price or dividend as Attarat capacity of 554MW will offset the decommission of Paka 585MW.

With Paka plant operation ending 30/6/2021, expect reduction quarterly in revenue of 10% and 35% PAT in Q4 2021 result.

Attarat issue will probably be resolved by year end.

Likely new contributions from Attarat may come after Q3 2022

Wrong channel?
Should have posted to Twitter, Facebook or NST/STar newspaper

@pjseow

https://disclosure.bursamalaysia.com/FileAccess/apbursaweb/download?id=213850&name=EA_FR_ATTACHMENTS

https://focusmalaysia.my/featured/glove-average-selling-price-is-not-expected-to-fall-off-a-cliff/

https://seekingalpha.com/article/4428004-top-glove-glove-price-decline-and-dual-listing-draw-attention

https://www.theedgemarkets.com/article/glove-stocks-red-amid-concerns-over-mounting-pressure-selling-prices-and-overcapacity

stockwin, the computation is not correct even with assumptions.

Currently, ASP are declining approximately 10% every quarter.

And ASP is a key component in revenue.

If CBP blacklist Supermax, ASP should reduce further as American market has 5% premium in ASP.

Actually, KPOWER and SCIB also have same modus operandi, 2 PP in the last 12 months

Mabel, I believe Karim may not be aware of the issue.

The focus is on his subordinates whether clean or dirty.

Time will tell.

I don't think anyone cares about this.
Out of 1,000 ppl here, at least 70% are punters/day traders/short term(<3mths) trader which can be justified by the volume generated.

Anyone looking into Pfizer, J&J AZ,etc?

Pinky, revenues and profit are number that can be manipulated.

You can read Enron Scandal as a case study.

No Foxconn?

In a filing with Bursa Malaysia, it said the company has yet to engage with any potential strategic partners and investors in relation to its recently approved private placement exercise.


https://www.thestar.com.my/business/business-news/2021/06/02/dnex-no-decision-yet-on-investors

Serba Dinamik announced a number of issues KPMG had raised, including sales transactions and trade receivables, some of which involved transactions of RM2.32 billion.

KPMG also took issue with suppliers that had similar registered addresses and a paid-up capital of only RM100,000 each, “where supplier is owned by an individual shareholder despite having transactions which range from between RM60 million and RM96 million”. In total, these transactions amounted to RM481 million.

Also at issue is a customer and supplier in Bahrain whose office address could not be located. Serba Dinamik, however, says KPMG had sighted the wrong address. These transactions total US$101 million, along with trade receivables’ balance of US$24 million.

KPMG was also unable to determine the appropriateness of some contracts, transactions, as well as the revenue, but these have been disputed by Serba Dinamik.

Suggest everyone to stay sideline first till clearer picture of the issue of inflated project value and revenues.

Stay safe.

Really disgusted to see US CBP pointing out without facts.

Previously was Topglove, after 1 year still not resolve.

Now Supermax also included.

Yeah, the concern is overstated or inflated project values, revenue,etc

Maxtrader, KPOWER had nothing to do with Serba, but the method of getting the projects is similar to Serba.

Notice that Serba started to get many large projects during 2020 and pandemic period. Likewise SCIB and KPOWER, similar shareholder with influence.

Though I hope it is not.

The US CBP is finding fault with everyone, and now Supermax.

https://www.malaymail.com/news/malaysia/2021/05/31/malaysias-supermax-says-abiding-by-labour-laws-after-report-on-u.s.-probe/1978377

Still wondering the logic of the PP.

Isn't will dilute existing major shareholders?

But it's interesting to know how many tranches of pp and who is the buyer.

Stenta contributes eps by 2.96 cent.

Very minimal contribution to the entire company as a whole.

Key importance is how Stenta value can be injected into the existing packaging biz and integrate for better efficiency.

Result coming out in a few weeks.

Numbers to lead the price action.

It's called demand normalization process and will continue until it hits equilibrium.

Y-O-Y result is impressive.

Q-O-Q result is satisfactory

Quite good considering the covid pandemic

wow, impressive rebound.

Result is impressive Y-O-Y.

Satisfactory Q-O-Q.

In this Covid-19 pandemic, consider quite good.

A little disappointed, PAT didn't reach my target rm100mil.

Just monitor the result to determine your outcome to keep/buy or sell.

Let the numbers do the talking.

Those selling, do leave the forum, else don't see the point keep shouting sell or doom/gloom, unless you are missed the boat and wanted cheap entry price.

Inari came down from 52-week high of rm3.75 to below RM3. Good deal to buy, if you are not buying or selling, what are you doing here?

Everyone have different opinion on glove.

Those who think over in the longer term >5 years, is still correct. Glove has no replacements.

Those who think glove rally is over is also correct, those entered at 0.70(adj for bonus issue) would already made more than 1,200% return in less than 1year , taken profit from the market.

Those who think for swing trade is possible, is also correct, many new covid resurgence and new waves. Vaccine is definitely working to reduce the death rate.

No need to argue.

Everyone is correct.

KYY missed out 1 sentence: I am obliged to inform you that LCTITAN is one of my major investment. I am not asking to buy but if you decide to buy, you are doing it at own risk.

@Valgrovest

Refer to Lawson revenue and profit for last 5 years.


https://www.reuters.com/companies/2651.T/financials

@Valgrovest


Refer to CU mart revenue and profit for last 5 years.

https://www.reuters.com/companies/282330.KS/financials

@Valgrovest

Refer to family mart revenue and profit for last 5 years.


https://asia.nikkei.com/Companies/FamilyMart-Co.-Ltd

Lack of foreign workers to harvest

I believe CU store is quite similar with the family mart and K-mart which already in the market for some time.

Don Don Donki, also spreading its wing to Msia recently.

Too many of these store concept but low profit margin will expect fierce competition for market share and of course razer thin PAT.

Just wondering why no one comes out with premium outlet with fat PAT.

Even if that is true, ytd Nasdaq had appreciated 1,000 points and last 52-weeks gained 4,000 points and last 60-mths surge 9,000 points.

Correction of 1,000 points seemed reasonable.

Eat healthily with frequent exercise and yearly body checkup and avoid the stock market if it creates stress and sleepless nights.

Useful information from Nomura. Thumbs up.

You are right.

Go for others if you want short term.

Yeah.
Stock don't go up or down in straight line.

There's ppl who buy and some who sell.

Buy the growth story or sell the company is no longer able to grow.

Simple.

No need to publish up 12 cent, down 10 cent next day and repeat it daily.

We are aware of the price movements duh.

Yeah, don't really understand why need PP at this time.
The company is not short of cash.

Any increase in capacity or new equipment can be added gradual as customer normally provide staggered demand throughout a few years.

petramaises , i disagree.

Glove companies production capacity had been growing year on year since the 1st day the started operations.

The supernormal profit only kicks in when they are high ASP prices.

Before pandemic, most asp are between USD18-USD22 per 1000 pcs depends on types of glove.

Today asp (with spot price) is between USD75-USD90 from peak of USD100-USD115. Blended asp is only between USD45-USD55.

Without the high asp, production capacity doesn't really help much as the additional capacity are normally allocated for spot price which is the highest asp which represents only less than 25% total capacity.

To be honest, very few people invest in glove stock before this pandemic. Go figure.